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ABSTRACT  
Approaches for studying antimicrobial susceptibility and discovering new antimicrobial agents from the plants and other natural sources have 
been extensively utilized. Withania somnifera (L.) Dunal, commonly known as Ashwagandha or Indian ginseng or winter cherry, is a popular 
medicinal plant in Ayurvedic medicine. The principal active compounds include several withanolide-type compounds. Various plant parts, like 
roots and less often leaves and fruits of Ashwagandha, have been used as plant-derived medicines. The plant possesses various pharmacological 
activities including antimicrobial activity. Many bacterial and fungal species have been used as a test microorganism for the assessment of the 
antimicrobial activity of extracts and purified compounds of various plant parts of Ashwagandha. In this article, we tried to compile and to 
discuss the information about the antimicrobial activity of W. somnifera. This will provide the platform for the researchers to select plants, plant 
parts, solvent system, test microorganisms, method of evaluation and other related factors affecting the analysis.  
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INTRODUCTION 
At present, microbial infections have turned out to be an 
important clinical warning, with significant allied sickness 
and death, which is mainly due to the increase in microbial 
resistance to the prevailing antimicrobial agents1,2. Hence, 
approaches for antimicrobial susceptibility  analysis and 
discovering new antimicrobial agents have been extensively 
utilized and continue to be developed3. 
After the revolution in the ‘golden era’, when nearly all 
groups of important antibiotics (cephalosporins, 
tetracyclines, aminoglycosides and macrolides) were 
discovered and the key difficulties of chemotherapy were 
resolved in the 1960s, the history repeats itself these days 
and these prevailing compounds are at risk of losing their 
effectiveness due to the increase in microbial resistance. 
Currently, its effect is considerable with treatment failures 
related to the multidrug-resistant bacteria and it has become 
a worldwide alarm to public health4. For this reason, the 
discovery of new antibiotics is an absolutely essential 
objective. Natural products, mostly plants are still one of the 
chief sources of new drug molecules today5,6. Microbial and 
plant products occupy the main part of the antimicrobial 
compound identified and discovered till date. Plants and 
other natural resources can deliver an enormous range of 
complex and structurally different compounds. Recently, 
many researchers have focused on the investigation of plant 
and microbial extracts, essential oils, pure secondary 
metabolites and newly synthesized molecules as probable 
antimicrobial agents7-10. The fact that a plant extract shows 
antimicrobial activity is of concern, but this primary part of 
the data should be reliable and let researchers to relate 
results, avoiding work in which researchers use the 
antimicrobial activity study only as a supplement to a 
phytochemical analysis3. 
Various methods are used for the assessment of the 
antimicrobial potential of plant extracts, essential oils and 
other antimicrobial agents which include, agar disk-diffusion 
method, antimicrobial gradient method, agar well diffusion 
method, agar plug diffusion method, cross streak method, 
poisoned food method, thin-layer chromatography (TLC)–
bioautography (agar diffusion, direct bioautography, agar 
overlay bioassay), dilution methods (broth dilution method, 
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agar dilution method), time-kill test (time-kill curve), ATP 
bioluminescence assay, flow cytofluorometric method3. A 
variety of laboratory methods can be used to screen or 
evaluate the in vitro antimicrobial activity of a pure 
compound or a plant extract. The widely used and basic 
methods are the disk/disc diffusion method and broth/agar 
dilution methods. Other methods are used especially for the 
testing of antifungal activity, like, poisoned food technique11. 
To further study the antimicrobial effect of an agent in depth, 
Time-kill test and flow cytofluorometric methods are 
endorsed for further in depth study of the effect of 
antimicrobial agents, which provide details on the nature of 
the inhibitory effect (bacteriostatic or bactericidal) 
(concentration-dependent or time-dependent) and the cell 
damage imposed to the test microorganism3. 
ASHWAGANDHA: AN IMPORTANT MEDICINAL 
PLANT 
Withania somnifera (L.) Dunal, commonly known as 
Ashwagandha or Indian ginseng or winter cherry, is a 
renowned medicinal plant in Ayurvedic medicine12. The 
principal active compounds include several withanolide-type 
compounds13,14. Due to the nonhazardous and great 
medicinal value, it is commonly used all over the world. 
Roots, and less often leaves and fruits, have been used as 
phytomedicines in the form of decoction, infusions, ointment, 
powder, and syrup13-15. These days, it is cultivated as a crop 
to maintain the high demand of biomass and a sustainable 
eminence for the requirements of pharmaceutical industry16.  
Ashwagandha is an important herb in the Ayurvedic and 
indigenous medicine system for over 3000 years. It belongs 
to the family Solanaceae and possess a chromosome number 
of 2n=48. In the India, only two species of Withania are found 
which includes W. somnifera and W. coagulans17. This plant 
has been used as a home remedy for numerous diseases in 
the India and many parts of the world. It is found in the wild 
form in many parts of the India and in the Mediterranean 
region of North Africa. In the India, it is grown in Rajasthan, 
Madhya Pradesh, Himachal Pradesh, Punjab and Uttar 
Pradesh17. It is designated as an herbal tonic and health food 
in the Vedas and is considered as ‘Indian ginseng’ in the 
conventional Indian medicine. It is utilized as a liver tonic, 
anti-inflammatory, antioxidant, antimicrobial agent and cure 
for asthma18. Withaferin-A has been receiving a good deal of 
attention because of its antibiotic and antitumor activity19.  
In Unani system of medicine, roots of W. somnifera usually 
known as Asgand are utilized for the medicinal properties20. 
In Ayurveda, Ashwagandha is claimed to have effective 
aphrodisiac rejuvenating and life extending properties. It has 
overall animating and regenerative abilities and is used 
among others, for the treatment of nervous exhaustion, 
insomnia, memory related conditions, skin problems, 
tiredness potency issues and coughing. It also increases 
learning capability and memory capacity. The traditional use 
of Ashwagandha was to escalate energy, youthful vigor, 
strength, endurance, health, increase vital fluids, nurture the 
time elements of the body, muscle fat, lymph, blood, cell 
production and semen. It helps counteract chronic fatigue, 
dehydration, weakness, loose teeth, bone weakness, 
impotency, thirst, premature aging emaciation, muscle 
tension, debility and convalescence. It aids invigorate the 
body by rejuvenating the reproductive organs, just as a tree 
is invigorated by feeding the roots21. 
 
 
CHEMICAL CONSTITUENTS 
 
Figure 1: Chemical structure of (A) Withaferin A and (B) Withaolide A 
The chemical constituents of W. somnifera have always been 
of great interest to the scientific community. The biologically 
active chemical constituents are alkaloids (ashwagandhine, 
anahygrine, cuscohygrine, tropine etc), steroidal compounds 
i.e.  withaferin A, withasomniferin A, ergostane-type 
steroidal lactones, withanolides A-Y, withasomniferols A-C, 
withasomidienone, withanone etc22. Withaferin A (Figure 
1A), and withanolide A (Figure 1B) are the chief withanolidal 
active components isolated from the plant. These 
compounds are chemically similar but varied in their 
chemical constituents23. 
PHARMACOLOGICAL ACTIVITIES OF 
ASHWAGANDHA 
W. somnifera possesses various pharmacological activities 
(Figure 2) viz., anti-inflammatory activity, antibacterial 
activity, antifungal activity, antiviral activity, antitumour 
activity, immunomodulatory activity, anti-
stress/adaptogenic activity, anticonvulsant activity, 
neuropharmacological activity, musculotropic activity, anti-
oxidant activity, anti-ageing effect, anti-hyperglycaemic 
effect, macrophage-activating effect, hepatoprotective 
activity, morphine tolerance and dependence-inhibiting 
effect20.
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Figure 2: Pharmacological activities of Ashwagandha (W. somnifera) 
 
Antibacterial activity of Ashwagandha 
Many bacterial species have been used as a test 
microorganism for the assessment of the antimicrobial 
activity of extracts and purified compounds of W. somnifera. 
These bacterial strains were Acinetobacter baylyi, 
Agerobacterium tumefaciens, Bacillus cereus, Bacillus subtilis, 
Bacillus thuringiensis, Chlamydophila pneumonia, Citrobacter 
freundii, Corynebacterium diphtheriae, Enterobacter 
aerogens, Enterococcus  feacalis, Escherichia coli, Klebsiella 
pnemoniae, Lactic acid bacterial (LAB) strains, Methicillin 
Resistance Staphylococcus aureus, Micrococcus luteus, 
Neisseria gonorrhea, Proteus mirabilis, Proteus solanacearum, 
Proteus vulgaris, Pseudomonas aeruginosa, Pseudomonas 
fluorescens, Raoultella planticola, Salmonella typhi, 
Salmonella typhimurium, Serratia marcescens, Staphylococcus 
aureus, Staphylococcus epidermis, Streptococcus pyogenes, 
Xanthomonas axonopodis pv. malvacearum, Yersinia 
enterocolitica and few others. The detailed compilation of 
information regarding the antibacterial activity of W. 
somnifera is given in Table 1. 
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Table 1: Antibacterial activity of Ashwagandha (W. somnifera) 
Sr. 
no. 
Plant part 
used 
Solvent used for 
extraction 
Method 
used 
Test microorganisms References 
1. Le M, H, DEE DD Salmonella typhimurium, 
Escherichia coli 
24 
2. Ro E AWD Salmonella typhimurium 25 
3. Le M AWD Neisseria gonorrhea 26 
4. Le M DD Bacillus subtilis, 
Escherichia coli, 
Pseudomonas fluorescens, 
Staphylococcus aureus, 
Xanthomonas axonopodis pv. 
malvacearum 
27 
5. Ro M DD Escherichia coli, 
Proteus vulgaris, 
Proteus solanacearum 
28 
6. Ro, St, Le, Ca C DD Escherichia coli, 
Staphylococcus aureus, 
Raoultella planticola 
29 
7. Ro M, E, BU AWD Staphylococcus aureus 30 
8. Le E AWD Staphylococcus aureus, 
Bacillus subtilis, 
Escherichia coli, 
Pseudomonas aeruginosa 
31 
9. Ro, Fr, Le 
 
M AWD Escherichia coli, 
Salmonella typhi, 
Citrobacter freundii, 
Pseudomonas aeruginosa, 
Klebsiella pneumonia 
32 
10. Le, Fl E, A, IP, T, H DD Escherichia coli, 
Staphylococcus aureus, 
Raoultella planticola, 
Pseudomonas aeruginosa, 
Bacillus subtilis, 
Enterobacter aerogens 
33 
11. Fr, Ca B, C, W DD Pseudomonas aeruginosa, 
Bacillus subtilis, 
Enterobacter aerogens 
34 
12. Le E AWD Escherichia coli, 
Micrococcus luteus, 
Pseudomonas aeruginosa, 
Bacillus cereus, 
Klebsiella pneumonia, 
Staphylococcus aureus 
35 
13. St, Ro, Le A DD Bacillus subtilis, 
Methicillin Resistance Staphylococcus 
aureus, 
Streptococcus pyogenes,  
Enterococcus  feacalis, 
Escherichia coli, 
Pseudomonas aeruginosa, 
Klebsiella pnemoniae 
36 
14. Ro 
 
H, PE, T, B, IP, C, EA, A, 
E, GAA, W 
DD Proteus mirabilis, 
Klebsiella pnemoniae, 
Agerobacterium tumefaciens 
37 
15. Ro EA AWD Staphylococcus aureus, 
Methicillin Resistance Staphylococcus 
aureus 
38 
16. Ro E  DD Bacillus subtilis, 
Escherichia coli, 
Klebsiella pnuemoniae, 
Pseudomonas aeruginosa, 
Salmonella typhi 
39 
17. Le M AWD Staphylococcus aureus, 
Enterococcus spp. 
40 
18. St 
 
EA, H, M, DW AWD Serratia marcescens, 
Bacillus cereus, 
Pseudomonas aeruginosa,  
18 
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Escherichia coli 
19. Ro W TFSD Escherichia coli 41 
20. Ro 
 
M AWD Staphylococcus aureus, 
Bacillus cereus, 
Micrococcus luteus, 
Escherichia coli, 
Pseudomonas aeruginosa, 
Klebsiella pneumonia 
42 
21. Ro M DD Bacillus cereus, 
Staphylococcus aureus, 
Staphylococcus epidermis, 
Salmonella typhi, 
Escherichia coli, 
Pseudomonas aeruginosa 
43 
22. Le E, M, A, W AWD Bacillus cereus, 
Serratia sp. 
44 
23. Le C DD Corynebacterium diphtheriae, 
Pseudomonas aeruginosa, 
Bacillus thuringiensis, 
Corynebacterium diphtheria, 
Salmonella typhi, 
Chlamydophila pneumoniae 
45 
24. Le M AWD Bacillus subtilis, 
Escherichia coli, 
Staphaylocuccus aureus, 
Pseudomonas fluorescens 
46 
25. Le M AWD Lactic acid bacterial (LAB) strains 47 
26. Ro M, DIW, C, H, EA DD Proteus mirabilis, 
Klebsiella pneumonia, 
Acinetobacter baylyi, 
Streptococcus pyogenes, 
Pseudomonas aeruginosa 
48 
27. Le E, C+H DD  Escherichia coli 49 
A: Acetone, B: Benzene, BU: Butanol, C: Chloroform, DIW: Deionised Water, DEE: Diethyl Ester, DW: Distilled Water, E: Ethanol, 
EA: Ethyl Acetate, GAA: Glacial Acetic Acid, H: Hexane, IP: Isopropanol M: Methanol, PE: Petroleum Ether, W: Water, AWD: Agar 
Well Diffusion, DD: Disc Diffusion, TFSD: Two-Fold Serial Dilutions, Ca: Calyx, Fr: Fruit, Le: Leaves, Fl: Flower, Ro: Root, St: Stem 
 
Various plant parts viz., calyx, fruit, leaves, flower, root and 
stem of Ashwagandha were used by researchers in the past, 
but leaves and roots were used in most of the studies. 
Different solvents like, acetone, benzene, butanol, 
chloroform, chloroform+hexane, deionised water, diethyl 
ester, distilled water, ethanol, ethyl acetate, glacial acetic 
acid, hexane, isopropanol, methanol, petroleum ether, 
toluene and water have been used for the extraction of 
chemical constituents from various plant parts of 
Ashwagandha but methanol was the mostly used solvent for 
the extraction. From the literature survey, we have found 
that disc diffusion method was the most preferred method 
for the evaluation of the antimicrobial efficacy of 
Ashwagandha plant extracts. 
Antifungal activity of Ashwagandha 
In the past, antifungal activity activity has been evaluated for 
various extracts of different plant parts of Ashwagandha. 
The detailed information on the antifungal activity of 
Ashwagandha is provided in the Table 2. Many test fungal 
species including, Alternaria brassica, Aspergillus flavus, 
Aspergillus fumigatus, Aspergillus niger, Aspergillus oryzae, 
Candida albicans, Candida kefy, Candida tropicalis, 
Cryptococcus neoforman, Dreschlera turcica, Fusarium 
oxysporum f. sp. cepae, Fusarium oxysporum, Fusarium 
verticilloides, Penicillium chrysogenum, Penicillium citrinum 
and Trichoderma viridae were used for the assessment of the 
antifungal activity of Ashwagandha. 
 
 
 
 
 
 
 
 
 
 
 
Khanchandani  et el                                                                                         Journal of Drug Delivery & Therapeutics. 2019; 9(5-s):154-161 
ISSN: 2250-1177                                                                                  [159]                                                                                 CODEN (USA): JDDTAO 
Table 2: Antifungal activity of Ashwagandha (W. somnifera) 
Sr. 
No. 
Plant part 
used 
Solvent used for 
extraction 
Method 
used 
Test microorganisms References 
1 Le  M DD Aspergillus flavus, 
Dreschlera turcica, 
Fusarium verticillioides 
27 
2 Le M DD Aspergillus fumigatus, 
Aspergillus niger 
50 
3 Ro PG DD Fusarium oxysporum, 
Fusarium verticilloides, 
Aspergillus flavus 
51 
4 Le, Fl E, A, IP, T, H DD Candida albicans, 
Aspergillus flavus 
33 
5 Fr, Ca B, C, W DD Candida albicans 34 
6 Le E, M, EA, A, C, PE, H, 
W (Hot) 
AWD Aspergillus niger, 
Candida albicans, 
Candida tropicalis, 
Candida kefy, 
Cryptococcus neoforman 
35 
7 St H, EA, M, W AWD Aspergillus niger, 
Aspergillus flavus, 
Aspergillus oryzae, 
Penicillium chrysogenum, 
Trichoderma viridae 
18 
8 Ro M, W AWD Candida albicans 26 
9 Fr, Ca B, C, W DD Aspergillus niger 34 
10 Ro H, PE, T, B, IP, C, EA, 
A, E, GAA, W  
DD Aspergillus niger 37 
11 Ro H DD Fusarium oxysporum, 
Alternaria brassica 
28 
12 Le E, M, A, W (hot &  
old) 
PFT Aspergillus flavus, 
Penicillium citrinum 
44 
13 Ro E DD Candida albicans 52 
14 Fr, St, Ro M DD Fusarium oxysporum f. sp. cepae 53 
A: Acetone, B: Benzene, BU: Butanol, C: Chloroform, DIW: Deionised Water, DEE: Diethyl Ester, DW: Distilled Water, E: 
Ethanol, EA: Ethyl Acetate, GAA: Glacial Acetic Acid, H: Hexane, IP: Isopropanol M: Methanol, PG: Purified Glycoprotein, PE: 
Petroleum Ether, W: Water, AWD: Agar Well Diffusion, DD: Disc Diffusion, PFT: Poison Food Technique, Ca: Calyx, Fr: Fruit, 
Le: Leaves, Fl: Flower, Ro: Root, St: Stem 
 
Various plant parts viz., calyx, flower, fruits, leaves, root and 
stem were used for the antifungal activity assessment. 
Mostly used plant part was the root of Ashwagandha. 
Acetone, benzene, chloroform, ethanol, ethyl acetate, glacial 
acetic acid, hexane, isopropanol, methanol, petroleum ether, 
toluene and water (hot and cold) were used as a solvent for 
the extraction procedure to evaluate antifungal activity of 
various parts of Ashwagandha. However, methanol was the 
most preferred solvent for the extraction of phytochemicals 
from parts of Ashwagandha. Like antibacterial activity 
assessment, most chosen method for the evaluation was the 
disc diffusion method. However, agar well diffusion method 
and poison food technique were also used for the evaluation. 
Some common concerns must be established to evaluate the 
antimicrobial activity of plant extracts, essential oils and the 
isolated/extracted compounds from them. The greatest 
relevance is the characterizing and defining common factors, 
such as plant parts used, methods employed, growth medium 
and test microorganisms evaluated (Rios and Recio, 2005). 
Systematic standards should be used in the selection and 
collection of the plant parts/materials. Moreover, to avoid 
unnecessary exercise, the selection of plants and plant parts 
should be made from an ethnopharmacological perception. 
The solvent systems and the extraction procedure may alter 
the final outcome of the study. The solvents and methods for 
extraction used in folk medicine should be used as they are 
most appropriate. The active chemical constituents are more 
soluble in some solvents, which should be used as it may 
affect the results. The crude extract or essential oil offers 
variable results as they contain different phytochemicals 
present in them. The presence of such active phytochemicals 
depends on their solubility in the solvents used. Sometimes, 
the presence of phenolic, carboxylic compounds or other 
impurities in the extract may affect the activity of the active 
phytochemicals. The experiments may be carried out with a 
collection of strains, but additional experiments with isolated 
pathogens would be of importance in the case of purified 
compounds or active extracts to evaluate their actual effects. 
According to the literature the evaluation of medicinal plants 
as antimicrobial agents, understanding medicinal flora and 
their real value is important, however the use of a standard 
technique for the research is also crucial. As the reports 
suggest, W. somnifera possesses significant antimicrobial 
activity, various types of research on the mechanisms of 
action, interactions of microorganisms with plant extracts 
and the pharmacokinetic profile of the extracts should be 
given main concern (Rios and Recio, 2005). 
CONCLUSION: 
Ashwagandha (W. somnifera) owns a tremendous amount of 
medicinal properties including antimicrobial activity. Many 
test microorganisms have been used for the assessment of 
the antimicrobial activity of extracts and purified compounds 
of various plant parts of Ashwagandha. Still, there are many 
scopes of the research or the identification and isolation of 
antimicrobial agents from Ashwagandha. The information 
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provided in this article will provide the platform for the 
researchers to select plants, plant parts, solvent system, test 
microorganisms, method of evaluation and other related 
factors affecting the analysis. 
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